HC
GILD icon

HNP Capital’s Gilead Sciences GILD Stock Holding History

HNP Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$810K Sell
9,758
-319
-3% -$26.4K 0.23% 84
2022
Q4 		$865K Sell
10,077
-265
-3% -$21K 0.24% 79
2022
Q3 		$638K Sell
10,342
-137
-1% -$8.64K 0.18% 89
2022
Q2 		$648K Sell
10,479
-193
-2% -$11.9K 0.18% 96
2022
Q1 		$634K Sell
10,672
-792
-7% -$50.6K 0.15% 103
2021
Q4 		$832K Buy
11,464
+524
+5% +$36.1K 0.19% 96
2021
Q3 		$764K Buy
10,940
+271
+3% +$19K 0.19% 97
2021
Q2 		$735K Buy
10,669
+303
+3% +$20.2K 0.19% 96
2021
Q1 		$670K Buy
+10,366
New +$668K 0.2% 97

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HNP Capital's GILD Position: Q1 2023 in Review

HNP Capital reduced its Gilead Sciences (GILD) stake by 3.2% in Q1 2023, selling an estimated $26.4K and leaving 9,758 shares worth $810K. The position accounts for 0.23% of the portfolio, ranked #84.

HNP Capital first reported a position in GILD in Q1 2021 and has held it in 9 quarters since. The position peaked at $865K in Q4 2022. 1,735 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

  • HNP Capital held 9,758 shares of Gilead Sciences worth $810K as of Q1 2023.
  • HNP Capital sold 319 Gilead Sciences shares in Q1 2023, an estimated $26.4K.
  • Gilead Sciences made up 0.23% of HNP Capital's portfolio in Q1 2023, its #84 holding.
  • HNP Capital first reported a position in Gilead Sciences in Q1 2021 and has held it in 9 quarters since.
  • HNP Capital's Gilead Sciences position peaked at $865K in Q4 2022.
  • 1,735 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on HNP Capital's 13F filing for Q1 2023, filed 18 May 2023.